BlockBeats News, December 10, RaveDAO today officially released the airdrop claim guide, clarifying the airdrop distribution rules and time window for Genesis founding members and community members who participated in RaveDAO activities during 2024–2025. This airdrop aims to reward users who made a genuine contribution to the ecosystem through on-chain interactions, in-person event check-ins, and community building before RaveDAO's token launch. All airdrops will be distributed sequentially after the token generation event (TGE) on December 12.
RaveDAO Genesis founding members are the first batch of recipients for the airdrop. Users need to go to PLVR (RaveDAO's official ticketing platform) → My Membership → RaveDAO → My Points to view their points and complete the Base network wallet address confirmation on the desktop. Users who have previously submitted their addresses during the minting phase must reconfirm to receive the airdrop; otherwise, they will not receive it.
Officially announced three wallet submission time windows corresponding to different distribution schedules:
Window One (December 10, 8 AM UTC – December 11, 12 PM UTC), to receive the airdrop no later than 11:59 PM UTC on December 12
Window Two (December 11, 12 PM UTC – December 18, 12 PM UTC), to receive the airdrop no later than 11:59 PM UTC on December 19
Window Three (December 18, 12 PM UTC – January 11, 12 PM UTC), to receive the airdrop no later than 11:59 PM UTC on January 12
After the $RAVE distribution is completed, the system will automatically deduct the corresponding amount of RAVE points from users' point accounts.
The community airdrop (2024–2025 activity participants) will be launched as the second phase, targeting users who have verified their participation in RaveDAO's global flagship events, local Chapters, and official partner events through the ticketing platform. Point distribution and claim windows will be announced later.
Furthermore, the Genesis Rewards lottery will launch after TGE and will feature on-chain verifiable randomness provided by ARPA Randcast. The prize pool includes:
25,000 RAVE Points (1 winner)
Tomorrowland Double Ticket + Pass Package (1 person)
RaveDAO Lifetime VIP (3 people)
RaveDAO Lifetime GA (10 people)
RaveDAO reminds users to always obtain information through official channels to beware of phishing links and airdrops:
Official Website: https://ravedao.com
Twitter: https://x.com/RaveDAO
Telegram Group: https://t.me/ravedao
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.














Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.